Stellantis Recalls Over 1.5 Million Ram 1500 Trucks for Seat Belt Defect
The global recall affects 2019-2026 Ram 1500 models due to a potentially faulty second-row seat belt anchor; the automaker is aware of one potentially related injury.
Latest by Marcus Chen
TSX Futures Edge Higher Ahead of GDP Data, Tracking Global Equity Rally
Futures for Canada's main stock index posted modest gains Friday morning, supported by a global tech-led rally and strength in commodities, as investors awaited key domestic economic growth figures.
BofA: Forward Inflation Is Now the Key Test of Fed Credibility
Bank of America analysts say forward inflation measures have become the primary gauge of the Federal Reserve's credibility, as markets question if the central bank will match its rhetoric with action.
BioAge Labs Stock Plummets Over 50% After Novo Nordisk Trial Casts Doubt on Drug Strategy
Shares of BioAge Labs nosedived after a late-stage clinical trial failure from Novo Nordisk raised significant concerns about the scientific approach behind BioAge's lead cardiovascular drug candidate.
Morgan Stanley Downgrades China 2024 GDP Forecast to 4.6% on Weak June Data
The investment bank trimmed its full-year growth projection by 20 basis points, citing a persistent property downturn, weak consumption, and slowing infrastructure spending.
European Corporate Earnings Beat Expectations, Hitting 3-Year Growth Peak, Goldman Sachs Reports
European companies are posting stronger-than-expected earnings, with first-half profit growth reaching a three-year high of 13% despite economic headwinds, according to an analysis by Goldman Sachs.
Monte Rosa Therapeutics Stock Plummets on Novo Nordisk Trial Failure
Shares of Monte Rosa Therapeutics (GLUE) fell nearly 30% after a failed clinical trial by Novo Nordisk for a related anti-inflammatory drug raised concerns about the viability of Monte Rosa's own pipeline.
Bank of England Poised to Slow Bond Sales to £50 Billion Pace, Survey Shows
A survey of market participants indicates the Bank of England is expected to reduce the annual pace of its quantitative tightening program to £50 billion, down from the current £70 billion.
L'Oréal Well-Positioned in Shifting Beauty Market, Barclays Says
Barclays analysts highlighted L'Oréal as a key beneficiary of resilient premium beauty demand, citing competitor Puig's recent results which point to consumer shifts toward dermocosmetics and brand strength.